The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Glycopeptide antibiotics: Back to the future
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Platforms for antibiotic discovery
Lewis, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3975 · Cited by 1,445
Hiramatsu, K., Aritaka, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y., & Kobayashi, I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)07324-8 · Cited by 1,333
The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis
Sauvage, E., Kerff, F., Terrak, M., Ayala, J. A., & Charlier, P. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00105.x · Cited by 1,317
Phillips, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg483 · Cited by 1,100
Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-09 · Cited by 962
Vancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Levine, D. P. (2006) · Clinical Infectious Diseases · doi:10.1086/491709 · Cited by 838
Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions
Weidenmaier, C., & Peschel, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1861 · Cited by 774
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Drugs and the Pharmaceutical Sciences
(2010) · Drugs and the pharmaceutical sciences · doi:10.1201/ihcdruphasci · Cited by 586
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609839104 · Cited by 538
van Hal, S. J., Lodise, T. P., & Paterson, D. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir935 · Cited by 512
Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M.-N., Ploy, M.-C., El Solh, N., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.5-14.2003 · Cited by 492
Progress in Industrial Microbiology
Shelton, L. R. (1965) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/48.2.451a · Cited by 484
Tenover, F. C., & Moellering, R. C. (2007) · Clinical Infectious Diseases · doi:10.1086/513203 · Cited by 452
Ristocetin - A New Tool in the Investigation of Platelet Aggregation
Howard, M. A., & Firkin, B. G. (1971) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653684 · Cited by 450
Antibiotics in the clinical pipeline in 2013
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2013) · The Journal of Antibiotics · doi:10.1038/ja.2013.86 · Cited by 433
Self-citationHiggins, D. L., Chang, R., Debabov, D. V., Leung, J., Wu, T., Krause, K. M., Sandvik, E., Hubbard, J. M., Kaniga, K., Schmidt, D. E., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1127-1134.2005 · Cited by 425
Wootton, M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.4.399 · Cited by 414
Community-associated MRSA: What makes them special?
Otto, M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.007 · Cited by 379
Hanaki, H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.199 · Cited by 366
New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin
Zhanel, G. G., Calic, D., Schweizer, F., Zelenitsky, S., Adam, H., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Hoban, D. J., & Karlowsky, J. A. (2010) · Drugs · doi:10.2165/11534440-000000000-00000 · Cited by 352
Fridkin, S. K., Hageman, J., McDougal, L. K., Mohammed, J., Jarvis, W. R., Perl, T. M., Tenover, F. C., & the Vancomycin‐Intermediate Staphylococcus aureus Epidemiology Study Group (2003) · Clinical Infectious Diseases · doi:10.1086/346207 · Cited by 344
Cui, L., Murakami, H., Kuwahara-Arai, K., Hanaki, H., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2276-2285.2000 · Cited by 318
History of the Development of Rifampin
Sensi, P. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.supplement_3.s402 · Cited by 315
Two New Genera of Nocardioform Actinomycetes: Amycolata gen. nov. and Amycolatopsis gen. nov.
LECHEVALIER, M. P., PRAUSER, H., LABEDA, D. P., & RUAN, J.-S. (1986) · International Journal of Systematic Bacteriology · doi:10.1099/00207713-36-1-29 · Cited by 312
Large-Scale Metagenomic-Based Study of Antibiotic Resistance in the Environment
Nesme, J., Cécillon, S., Delmont, T. O., Monier, J.-M., Vogel, T. M., & Simonet, P. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.036 · Cited by 311
Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine
Sheldrick, G. M., Jones, P. G., Kennard, O., Williams, D. H., & Smith, G. A. (1978) · Nature · doi:10.1038/271223a0 · Cited by 297
Mechanism of action of oritavancin and related glycopeptide antibiotics
Allen, N. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00144-4 · Cited by 276
Antibiotics in the clinical pipeline in 2011
Butler, M. S., & Cooper, M. A. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.44 · Cited by 272
Self-citationTotal Syntheses of Vancomycin and Eremomycin Aglycons
Evans, D. A., Wood, M. R., Trotter, B. W., Richardson, T. I., Barrow, J. C., & Katz, J. L. (1998) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19981016)37:19<2700::aid-anie2700>3.0.co;2-p · Cited by 268
Peschel, A., Vuong, C., Otto, M., & Götz, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2845-2847.2000 · Cited by 248
Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics
Beauregard, D. A., Williams, D. H., Gwynn, M. N., & Knowles, D. J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.781 · Cited by 244
Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O’Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Gao, W., Christiansen, K. J., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir270 · Cited by 228
Antibiotic Discovery and Development
(2012) · Springer eBooks · doi:10.1007/978-1-4614-1400-1 · Cited by 222
Genetic Characterization of vanG , a Novel Vancomycin Resistance Locus of Enterococcus faecalis
McKessar, S. J., Berry, A. M., Bell, J. M., Turnidge, J. D., & Paton, J. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3224-3228.2000 · Cited by 210
Crystal structure of vancomycin
Schäfer, M., Schneider, T. R., & Sheldrick, G. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00156-6 · Cited by 203
Glycopeptide antibiotic biosynthesis
Yim, G., Thaker, M. N., Koteva, K., & Wright, G. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.117 · Cited by 202
Total Synthesis of the Vancomycin Aglycon
Boger, D. L., Miyazaki, S., Kim, S. H., Wu, J. H., Castle, S. L., Loiseleur, O., & Jin, Q. (1999) · Journal of the American Chemical Society · doi:10.1021/ja992577q · Cited by 201
Vancomycin, a new antibiotic. I. Chemical and biologic properties.
Mh, M., Jm, M., PITTENGER, G. E., Pittenger, R. C., & Wm, S. (1955) · PubMed · Cited by 189
Nicolaou, K. C., Mitchell, H. J., Jain, N. F., Winssinger, N., Hughes, R. O., & Bando, T. (1999) · Angewandte Chemie International Edition · Cited by 187
Pootoolal, J., Thomas, M. G., Marshall, C. G., Neu, J. M., Hubbard, B. K., Walsh, C. T., & Wright, G. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102285099 · Cited by 185
Transferable Vancomycin Resistance in a Community-Associated MRSA Lineage
Rossi, F., Diaz, L., Wollam, A., Panesso, D., Zhou, Y., Rincon, S., Narechania, A., Xing, G., Di Gioia, T. S. R., Doi, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1303359 · Cited by 182
Reductive Alkylation of Glycopeptide Antibiotics: Synthesis and Antibacterial Activity.
COOPER, R. D. G., SNYDER, N. J., ZWEIFEL, M. J., STASZAK, M. A., WILKIE, S. C., NICAS, T. I., MULLEN, D. L., BUTLER, T. F., RODRIGUEZ, M. J., HUFF, B. E., et al. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.575 · Cited by 181
Sieradzki, K., & Tomasz, A. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.24.7103-7110.2003 · Cited by 181
Lunde, C. S., Hartouni, S. R., Janc, J. W., Mammen, M., Humphrey, P. P., & Benton, B. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-08 · Cited by 170
Origin, structure, and activity in vitro and in vivo of dalbavancin
Malabarba, A., & Goldstein, B. P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki005 · Cited by 167
Emergence of Teicoplanin Resistance During Therapy of Staphylococcus aureus Endocarditis
Kaatz, G. W., Seo, S. M., Dorman, N. J., & Lerner, S. A. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.1.103 · Cited by 166
Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)
LEADBETTER, M. R., ADAMS, S. M., BAZZINI, B., FATHEREE, P. R., KARR, D. E., KRAUSE, K. M., LAM, B. M. T., LINSELL, M. S., NODWELL, M. B., PACE, J. L., et al. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.326 · Cited by 165
van Hal, S. J., & Paterson, D. L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01133-10 · Cited by 165
Total Synthesis of Vancomycin—Part 1: Design and Development of Methodology
Nicolaou, K. C., Li, H., Boddy, C. N. C., Ramanjulu, J. M., Yue, T.-Y., Natarajan, S., Chu, X.-J., Bräse, S., & Rübsam, F. (1999) · Chemistry - A European Journal · doi:10.1002/(sici)1521-3765(19990903)5:9<2584::aid-chem2584>3.0.co;2-b · Cited by 159
Neoh, H., Cui, L., Yuzawa, H., Takeuchi, F., Matsuo, M., & Hiramatsu, K. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00534-07 · Cited by 156
Cui, L., Lian, J.-Q., Neoh, H., Reyes, E., & Hiramatsu, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3404-3413.2005 · Cited by 155
Hanaki, H., Labischinski, H., Inaba, Y., Kondo, N., Murakami, H., & Hiramatsu, K. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.3.315 · Cited by 155
Antibiotic resistance is ancient: implications for drug discovery
Wright, G. D., & Poinar, H. N. (2012) · Trends in Microbiology · doi:10.1016/j.tim.2012.01.002 · Cited by 154
Musta, A. C., RIEDERER, K. M., Shemes, S. P., Chase, P., Jose, J., Johnson, L. B., & Khatib, R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02135-08 · Cited by 153
The vanG glycopeptide resistance operon from Enterococcus faecalis revisited
Depardieu, F., Bonora, M. G., Reynolds, P. E., & Courvalin, P. M. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03737.x · Cited by 151
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
Candiani, G., Abbondi, M., Borgonovi, M., Romanò, G., & Parenti, F. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.2.179 · Cited by 150
Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health
Phillips, I. R. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.02.018 · Cited by 148
Cui, L., Neoh, H., Shoji, M., & Hiramatsu, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01173-08 · Cited by 147
Nicolaou, K. C., Natarajan, S., Li, H., Jain, N. F., Hughes, R. O., Solomon, M. E., Ramanjulu, J. M., Boddy, C. N. C., & Takayanagi, M. (1998) · Angewandte Chemie International Edition · Cited by 145
Pea, F. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg147 · Cited by 144
Structural modifications of glycopeptide antibiotics
Malabarba, A., Nicas, T. I., & Thompson, R. C. (1997) · Medicinal Research Reviews · Cited by 140
Xie, J. H., Pierce, J. G., James, R. C., Okano, A., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207142h · Cited by 140
Heteroresistance: a concern of increasing clinical significance?
Falagas, M. E., Makris, G. C., Dimopoulos, G., & Matthaiou, D. K. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01912.x · Cited by 140
Xie, J. H., Okano, A., Pierce, J. G., James, R. C., Stamm, S., Crane, C. M., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja209937s · Cited by 138
Structure elucidation of the teicoplanin antibiotics
Barna, J. C. J., Williams, D. H., Stone, D. J. M., Leung, T. W., & Doddrell, D. M. (1984) · Journal of the American Chemical Society · doi:10.1021/ja00329a044 · Cited by 136
Diastereoselective Total Synthesis of the Vancomycin Aglycon with Ordered Atropisomer Equilibrations
Boger, D. L., Miyazaki, S., Kim, S. H., Wu, J. H., Loiseleur, O., & Castle, S. L. (1999) · Journal of the American Chemical Society · doi:10.1021/ja990189i · Cited by 133
Dhand, A., & Sakoulas, G. (2012) · F1000 Medicine Reports · doi:10.3410/m4-4 · Cited by 131
The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
Howden, B. P., Peleg, A. Y., & Stinear, T. P. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.03.047 · Cited by 128
Teicoplanin versus vancomycin for proven or suspected infection
Cavalcanti, A. B., Gonçalves, A., Almeida, C. S., Bugano, D. D. G., & Silva, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007022.pub2 · Cited by 127
A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
Guskey, M. T., & Tsuji, B. T. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.1.80 · Cited by 123
Future Challenges And Treatment Of Staphylococcus Aureus Bacteremia With Emphasis On MRSA
Rasmussen, R. V., Fowler, V. G., Skov, R. L., & Bruun, N. E. (2010) · Future Microbiology · doi:10.2217/fmb.10.155 · Cited by 121
Reversion of the Glycopeptide Resistance Phenotype in Staphylococcus aureus Clinical Isolates
Boyle‐Vavra, S., Berke, S. K., Lee, J. C., & Daum, R. S. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.272-277.2000 · Cited by 121
Total Synthesis of Vancomycin Aglycon—Part 3: Final Stages
Nicolaou, K. C., Takayanagi, M., Jain, N. F., Natarajan, S., Koumbis, A. E., Bando, T., & Ramanjulu, J. M. (1998) · Angewandte Chemie International Edition · Cited by 120
Belley, A. C., McKay, G. A., Arhin, F. F., Sarmiento, I., Beaulieu, S., Fadhil, I., Parr, T. R., & Moeck, G. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00760-10 · Cited by 120
Staphylococci in Human Disease
(2009) · Wiley eBooks · doi:10.1002/9781444308464 · Cited by 118
Nicolaou, K. C., Jain, N. F., Natarajan, S., Hughes, R. O., Solomon, M. E., Li, H., Ramanjulu, J. M., Takayanagi, M., Koumbis, A. E., & Bando, T. (1998) · Angewandte Chemie International Edition · Cited by 117
Antibiotic resistance: An infectious arms race
Hede, K. (2014) · Nature · doi:10.1038/509s2a · Cited by 116
Gardete, S., Kim, C., Hartmann, B. M., Mwangi, M., Roux, C. M., Dunman, P. M., Chambers, H. F., & Tomasz, A. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002505 · Cited by 116
First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
Melo‐Cristino, J., Resina, C., Manuel, V., Lito, L., & Ramirez, M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61219-2 · Cited by 116
van Hal, S. J., & Fowler, V. G. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit178 · Cited by 113
Decreased Teicoplanin Susceptibility of Methicillin-Resistant Strains of Staphylococcus aureus
Mainardi, J., Shlaes, D. M., Goering, R. V., Shlaes, J. H., Acar, J. F., & Goldstein, F. W. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1646 · Cited by 111
Site-Selective Bromination of Vancomycin
Pathak, T. P., & Miller, S. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja301566t · Cited by 104
Nicolaou, K. C., Mitchell, H. J., Jain, N. F., Bando, T., Hughes, R. O., Winssinger, N., Natarajan, S., & Koumbis, A. E. (1999) · Chemistry - A European Journal · Cited by 103
Kosowska-Shick, K., Clark, C., Pankuch, G. A., McGhee, P., Dewasse, B. E., Beachel, L., & Appelbaum, P. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00742-09 · Cited by 101
Matsuo, M., Hishinuma, T., Katayama, Y., Cui, L., Kapi, M., & Hiramatsu, K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00398-11 · Cited by 100
Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium
Cooper, M. A., & Williams, D. H. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80008-3 · Cited by 85
Self-citationClinical relevance of increasing glycopeptide MICs against Staphylococcus aureus
Gould, I. M. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70002-5 · Cited by 85
Structure and mechanism of action of teicoplanin
Parenti, F. (1986) · Journal of Hospital Infection · doi:10.1016/0195-6701(86)90011-3 · Cited by 85
Allen, N. E., LeTourneau, D. L., & Hobbs, J. N. (1997) · The Journal of Antibiotics · doi:10.7164/antibiotics.50.677 · Cited by 85
Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
Patti, G. J., Kim, S. J., Yu, T., Dietrich, E., Tanaka, K. S. E., Parr, T. R., Far, A. R., & Schaefer, J. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.06.064 · Cited by 82
Treatment of Staphylococcal Septicemia with Vancomycin
Kirby, W. M. M., Perry, D. M., & Bauer, A. W. (1960) · New England Journal of Medicine · doi:10.1056/nejm196001142620201 · Cited by 81
Total Synthesis of Vancomycin—Part 3: Synthesis of the Aglycon
Nicolaou, K. C., Koumbis, A. E., Takayanagi, M., Natarajan, S., Jain, N. F., Bando, T., Li, H., & Hughes, R. O. (1999) · Chemistry - A European Journal · Cited by 81
Okano, A., James, R. C., Pierce, J. G., Xie, J. H., & Boger, D. L. (2012) · Journal of the American Chemical Society · doi:10.1021/ja302808p · Cited by 76
Roberts, J. A., Stove, V. V., Waele, J. J. D., Sipinkoski, B., McWhinney, B. C., Ungerer, J. P. J., Akova, M., Bassetti, M., Dimopoulos, G., Kaukonen, K.-M., et al. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.023 · Cited by 76
Matsuo, M., Cui, L., Kim, J., & Hiramatsu, K. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00425-13 · Cited by 75
Manson, J. M., Keis, S., Smith, J. M. B., & Cook, G. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.204-210.2003 · Cited by 70
Current State of Clostridium difficile Treatment Options
Venugopal, A. A., & Johnson, S. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis355 · Cited by 70
Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem
Katayama, Y., Murakami-Kuroda, H., Cui, L., & Hiramatsu, K. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-08 · Cited by 68
Semi-synthetic glycopeptide antibacterials
Judice, J. K., & Pace, J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.067 · Cited by 68
Community-Associated Methicillin-Resistant Staphylococcus aureus Case Studies
Sowash, M. G., & Uhlemann, A. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_2 · Cited by 65
Developing new antibacterials through natural product research
Kirst, H. A. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.779666 · Cited by 64
van Hal, S. J., Barbagiannakos, T., Jones, M., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr280 · Cited by 59
Kaur, H., Emsley, J., & Othman, M. (2013) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0033-1353442 · Cited by 56
Brink, A. J., Richards, G. A., Colombo, G., Bortolotti, F., Colombo, P., & Jehl, F. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.06.013 · Cited by 53
Corey, G. R., Stryjewski, M. E., Weyenberg, W., Yasothan, U., & Kirkpatrick, P. N. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3051 · Cited by 53
Plipat, N., Livni, G., Bertram, H. C., & Thomson, R. B. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2494-2496.2005 · Cited by 52
Treatment of Infections Due to Resistant Staphylococcus aureus
Anstead, G. M., Cadena, J., & Javeri, H. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-664-1_16 · Cited by 47
From Vancomycin to Oritavancin: The Discovery and Development of a Novel Lipoglycopeptide Antibiotic
Allen, N. E. (2010) · Anti-Infective Agents · doi:10.2174/187152110790886745 · Cited by 47
Bouza, E., & Burillo, A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.06.048 · Cited by 46
Teicoplanin Selects for Staphylococcus aureus That Is Resistant to Vancomycin
Shlaes, D. M., & Shlaes, J. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.4.1071 · Cited by 43
Ike, Y., Arakawa, Y., Ma, X., Tatewaki, K., Nagasawa, M., Tomita, H., Tanimoto, K., & Fujimoto, S. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.12.4445-4451.2001 · Cited by 40
Vancomycin CD and DE Macrocyclization and Atropisomerism Studies
Boger, D. L., Castle, S. L., Miyazaki, S., Wu, J. H., Beresis, R. T., & Loiseleur, O. (1998) · The Journal of Organic Chemistry · doi:10.1021/jo980880o · Cited by 39
Belley, A. C., Harris, R. J., Beveridge, T. J., Parr, T. R., & Moeck, G. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00603-08 · Cited by 39
Pinchman, J. R., & Boger, D. L. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4004494 · Cited by 38
Rodríguez, C. A., Agudelo, M., Zuluaga, A. F., & Vesga, Ó. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05129-11 · Cited by 37
Pfaller, M. A., Mendes, R. E., Sader, H. S., & Jones, R. N. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq335 · Cited by 36
Yamakawa, J., Kurosawa, H., Kaneko, K., Yamakawa, J., AMINAKA, M., Hori, S., Cui, L., Ito, T., Jin, J., Hiramatsu, K., et al. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-011-0330-2 · Cited by 35
Arhin, F. F., Sarmiento, I., Parr, T. R., & Moeck, G. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp286 · Cited by 35
Mendes, R. E., Sader, H. S., Flamm, R. K., Farrell, D. J., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02482-13 · Cited by 34
Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin
Cheng, M., Ziora, Z. M., Hansford, K. A., Blaskovich, M. A. T., Butler, M. S., & Cooper, M. A. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob42428f · Cited by 34
Self-citationRistocetins A and B, two new antibiotics; isolation and properties.
Je, P., SCHENCK, J. R., & Hargie, M. P. (1956) · PubMed · Cited by 33
Overcoming the challenges to developing new antibiotics
Shlaes, D. M., & Spellberg, B. J. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.06.010 · Cited by 30
Tattevin, P., Saleh‐Mghir, A., Davido, B., Ghout, I., Massias, L., de la Maria, C. G., Miró, J. M., Perronne, C., Laurent, F. J., & Crémieux, A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01669-12 · Cited by 30
Treviño, J., Bayón, C., Ardá, A., Marinelli, F., Gandolfi, R., Molinari, F., Jiménez‐Barbero, J., & Hernáiz, M. J. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201303310 · Cited by 26
Kobayashi, H., Shin‐ya, K., Nagai, K., Suzuki, K., Hayakawa, Y., Seto, H., Yun, B.-S., Ryoo, I., Kim, J.-S., Kim, C., et al. (2001) · The Journal of Antibiotics · doi:10.7164/antibiotics.54.1013 · Cited by 25
Sakoulas, G., Guram, K., Reyes, K., Nizet, V., & Zervos, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.00189-14 · Cited by 22
Vancomycin, a new antibiotic. III. Preliminary clinical and laboratory studies.
Griffith, R. S., & Peck, F. B. (2002) · PubMed · Cited by 22
Cell permeable vanX inhibitors as vancomycin re-sensitizing agents
Muthyala, R., Rastogi, N., Shin, W. S., Peterson, M. L., & Sham, Y. Y. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.097 · Cited by 17
Zhang, S., Yang, Q., Xu, L., Chang, J., & Sun, X. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.06.039 · Cited by 15
Krause, K. M., Blais, J., Lewis, S. R., Lunde, C. S., Barriere, S. L., Friedland, H. D., Kitt, M. M., & Benton, B. M. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.08.010 · Cited by 13
Taurand, P. (2008) · Springer eBooks · doi:10.1007/978-3-540-38918-7_5807 · Cited by 13
Glycopeptides and Lipoglycopeptides
Arhin, F. F., Belley, A. C., Far, A. R., Lehoux, D. E., Moeck, G., & Parr, T. R. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1400-1_9 · Cited by 10
Périchon, B., & Courvalin, P. M. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1400-1_15 · Cited by 8
Cited by
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Actinomycetes: Still a source of novel antibiotics
Genilloud, O. (2017) · Natural Product Reports · doi:10.1039/c7np00026j · Cited by 465
Antibiotics in the clinical pipeline at the end of 2015
Butler, M. S., Blaskovich, M. A., & Cooper, M. A. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2016.72 · Cited by 349
Self-citationAntibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
Domalaon, R., Idowu, T., Zhanel, G. G., & Schweizer, F. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00077-17 · Cited by 285
Developments in Glycopeptide Antibiotics
Blaskovich, M. A. T., Hansford, K. A., Butler, M. S., Jia, Z., Mark, A. E., & Cooper, M. A. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00258 · Cited by 265
Self-citation
Metadata
- Authors
- Butler, M. S., Hansford, K. A., Blaskovich, M. A. T., Halai, R., & Cooper, M. A.
- Venue
- The Journal of Antibiotics
- Published
- 2014-08-13
- Volume
- 67
- Issue
- 9
- Pages
- 631-644
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2034638097
- Cited by
- 303
- References
- 140
- FWCI
- 13.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.